Backed by Y CombinatorNest is an AI‑enabled software platform that helps organizations launch and scale longitudinal genomic programs, making precision medicine accessible at any stage of life.
Trusted by Healthcare Organizations Across the U.S.
Automate repetitive tasks, such as pedigree drawing and clinical notes, so you can focus on patient care.
One-click ordering from the lab of your choice on a single platform.
Generate evidence-based care plans specific to your patient needs.
Ordering, results, and clinical decision support happen seamlessly.
SMART on FHIR + FHIR APIs
HL7 / flat file / API options to match your environment
SSO options and role-based permissions
Structured and document results, plus longitudinal updates
Nest supports flexible lab configurations and standardizes the experience for patients and providers across labs.
Connect to your preferred lab partners with flexible routing and configuration options.
Customize test menus by program, clinic, or specialty to match your workflows.
Integrated results delivery and storage that fits seamlessly into your workflows.
Scale your genomic programs without re-platforming as your needs evolve.
Some of the labs we integrate with
Enter your patient volume to see projected outcomes based on real-world results from Nest implementations.
Nest helps teams increase access, reduce operational burden, and manage follow-up care.
0+
Patients served through the Nest platform
0%
of invited patients complete Nest
0x
Time from referral to results (or 40 days saved)
0x
Compared to traditional workflows
We built Nest because delivering genomic care at scale is hard: fragmented workflows, limited genetics expertise, and high operational burden. Nest brings the full program into one system—so organizations can launch and scale genetics without stitching together point solutions.
Learn More
Find eligible patients
Identify patients who meet genetic testing criteria using EMR signals and/or patient-reported data. Our AI-powered algorithms help you proactively surface patients who would benefit from genomic testing.